HMGB1 and Duchenne muscular dystrophy: Collectively, HMGB1 is shown to be increased in DMD-iSkMs and B10-mdx mice, which is reversed with AAV microdystrophin treatment, and should be considered for further biomarker verification of both disease status and treatment response.